Latest News

Here are the top 5 papers published by The American Journal of Managed Care and its sister publications about hepatitis C, treatment, and costs of care.
Dr Joe V. Selby on Biosimilar Research
The Patient-Centered Outcomes Research Institute (PCORI) will approach biosimilar research the way it does research on anything else, but there is the added element of finding the right timing, said Joe V. Selby, MD, MPH, executive director of PCORI.
Waiting until there's a cancer diagnosis or other crisis is not the time to be taking the family's medical history. Testing companies and genetic counselors encourage families to share information when they are all in one place.
The policy change is aimed at curbing the state's obesity rate as well as comorbidities such as diabetes
This Thanksgiving, as families gather around the table, health and wellness should be a topic of discussion.
What we’re reading, November 25, 2015: UnitedHealthcare's decision on healthcare exchange participation, Democratic Presidential candidate's health plan, and conflict of interest between soda company and anti-obesity research group.
The study was released Thanksgiving week. The Wednesday before the holiday has become one of the most dangerous nights of the year, with the number of violations for driving under the influence higher than Thanksgiving or Christmas Day.
Dr Glen Stettin on Strategies for Managing High-Cost Treatments
Glen D. Stettin, MD, senior vice president of clinical, research, and new solutions at Express Scripts, discusses what strategies for managing high-cost treatments aren't working and how they could be improved.

From the Journals

This commentary was adapted from an appearance by the authors at Patient-Centered Diabetes Care, a conference jointly presented by The American Journal of Managed Care and Joslin Diabetes Center.
Research at the University of Tennessee Health Sciences could lead to human trials in the next 2 to 3 years.
Several clinical trials under way are examining whether a new class of therapy approved to treat type 2 diabetes can also treat type 1.
A partnership between JDRF and Janssen Pharmaceuticals seeks ways to intercept the disease before it progresses.
Employer policies for access to maximum benefits do not always match those for access to obesity therapy.
Recommendations from primary care Meaningful Use “exemplars” are that clinical quality measures likely to improve outcomes should be evidence-based, high priority, actionable, and minimize burden.
Expanding and more representative participation in Medicare’s Bundled Payments for Care Improvement initiative suggests potential for large impact, pending the results of risk-bearing participants.
The American healthcare system is finally moving away from fee-for-service toward bundled payments, but this transition will only be successful if we shift risk to the physicians.
Diabetes Compendium
Oncology Compendium

Most Popular

AJMC Strategic Alliance